SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-006662
Filing Date
2022-03-11
Accepted
2022-03-11 16:55:11
Documents
15
Period of Report
2022-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40072
2 ex10-1.htm EX-10.1 68317
3 ex10-2.htm EX-10.2 52068
4 ex10-3.htm EX-10.3 87290
  Complete submission text file 0001493152-22-006662.txt   456338

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mslp-20220308.xsd EX-101.SCH 3042
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mslp-20220308_lab.xml EX-101.LAB 34476
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mslp-20220308_pre.xml EX-101.PRE 22601
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3178
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 22733839
SIC: 2834 Pharmaceutical Preparations